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The Surveillance Epidemiology and End Results data demonstrate that the risk of non-Hodgkin lymphoma is lower for women,
but that the incidence increases after ﬁfty years of age, at which menopause is regularly reached, suggesting that female hormones
may be protective for NHL. This study examines the inﬂuence of sex on lymphoma risk in a relevant large animal model. Records
for dogs in the Veterinary Medical Database were analyzed from 1964 to 2002. Risk ratios were calculated to evaluate associations
between sex, neutering status, and lymphoma occurrence. A total of 14,573 cases and 1,157,342 controls were identiﬁed. Intact
females had a signiﬁcantly lower risk of developing lymphoma, Odds Ratio 0.69 (0.63–0.74) with a P<. 001. We conclude that
there is a sex eﬀect on NHL risk in dogs similar to humans. We hypothesize that the hormone levels of intact females lower the risk
of NHL. The possibility of a protective role of endogenous estrogens in the etiology of NHL should be investigated.
Copyright © 2009 J. Armando Villamil et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Women are known to have a lower incidence of non-
Hodgkin lymphoma (NHL) than men (15.8 cases/100,000
person-years(py)versus23.2/100,000pyfrom1998to2002)
[1]. The observed diﬀerence has persisted over the past
two decades. Although the exact mechanism and cause of
the disparity is unknown, the interaction of hormones and
estrogen or progesterone receptors on gene expression has
been postulated as one logical mechanism. The ﬁnding of
speciﬁc polymorphisms in the estrogen receptor 1 associated
withhighersusceptibilitytolymphomasupportsahormonal
role in carcinogenesis [2].
Naturally occurring lymphoma is a common malignancy
in dogs. The NHL classiﬁcation schemes used in human
medicine have been adapted for use in dogs [3]. Investigators
have suggested that companion dogs can serve as an
important comparative model [4, 5]. The disease occurs
spontaneously in companion dogs with genetic, epigenetic,
histologic, therapeutic, and natural history similarities with
humans.Theshorterlifespanofdogscompressesprogression
time and permits more rapid study of disease epidemiology
and biological behavior [6]. Finally, dogs are exposed to
similar environmental and hormonal factors as humans
and may serve as an environmental sentinel and model of
prevention of NHL [7].
Hormonal inﬂuence on the causation, prevention, and
treatment has been well documented in the etiology of
several canine tumors. There is an established relationship
between the incidence of canine mammary tumors and the
timing of ovariectomy. Dogs spayed before their ﬁrst heat
cycle are signiﬁcantly less likely to develop mammary tumors2 Journal of Cancer Epidemiology
[8]. Perianal adenomas are considered to be androgen
dependent, occurring primarily in male intact dogs and
remittingfollowingcastration[9].Conversely,neuteredmale
dogshaveasigniﬁcantlyincreasedriskforallprostatecancers
when compared to their intact counterparts [10].
The etiologic inﬂuence of hormone status on the risk
of development of NHL has been examined in human
oncology. In a study of 37,220 Iowa women ages 55 to 69
years,currentusersofhormonalreplacementtherapywereat
increased risk for NHL [11]. Risk factors including endoge-
noussexhormones,ageatmenarche,ageatmenopause,type
of menopause, history of infertility, number of miscarriages,
history of induced abortion, number of livebirths, and
age at ﬁrst livebirth were evaluated and were not strongly
related to NHL incidence. A second study found an inverse
association with the number of breast-fed children, with
incidence for NHL decreasing after two children [12]. In
the evaluation of hormonal eﬀects on cancer development
in the human population, only females routinely experience
dramatic changes in sex hormone levels over their lifetimes.
Available information on similar eﬀects in the male popula-
tion is extremely limited. The dog population contains large
numbers of both intact and neutered individuals, allowing
the altering of endogenous hormone status to be evaluated
in a large epidemiologic study.
The Veterinary Medical Database (VMDB) is the most
comprehensive database in veterinary medicine. The VMDB
contains individual patient records from 27 North American
veterinary teaching hospitals, including more than 6 million
records of various animal species from 1964 to present.
The VMDB data permits comparisons between hormonally
intact and neutered dogs in both sex groups with a diagnosis
of canine lymphoma.
Canine lymphoma has historically been thought to be
more prevalent in males compared to females, but this
was based largely upon anecdotal information. An article
published by Dorn in 1970 reported that there was no
diﬀerencebetweensexesintheriskofdevelopinglymphoma;
[13] to date no other study has evaluated this speciﬁc
relationship. The purpose of this study was to examine
records from the VMDB to evaluate the relationship between
sex and lymphoma risk in dogs, with the hypothesis that
intact female dogs are at lower risk for NHL.
2.MaterialsandMethods
The VMDB was queried to identify all canine records
entered between 1964 and 2002. (VMDB’s URL
http://www.vmdb.org/ VMDB/CERF, PO Box 3007, 1717
Philo Rd, Suite 15,Urbana, IL 61803-3007. VMDB, Inc. does
not make any implicit or explicit opinion on the subject
of this study.) Cases were deﬁned as dogs with lymphoma,
including lymphoma type not speciﬁed (morphology code
8301), giant follicular lymphoma (morphology codes 8303
or 8330), or lymphosarcoma (morphology code 8310)
according to the Standard Nomenclature of Veterinary
Diseases and Operations (SNVDO). The control population
was deﬁned as all dogs with any diagnosis other than the 4
previously speciﬁed lymphoma diagnoses that never were
reported to have lymphoma. Because each oﬃce visit or
hospital stay results in the production of a unique entry in
the VMDB, individual dogs may enter the database multiple
times during their lifetime. Consequently, only a single,
randomly selected record was used for each individual
dog in the control population. For dogs with lymphoma,
we used data from the ﬁrst recorded visit in which the
diagnosis of lymphoma was listed. To ensure that each dog
was represented only once in the dataset, the data was sorted
by the patient identiﬁcation number and then ﬁltered using
SAS statistical software ( SAS for Windows, version 9.13, SAS
Institute Inc, Cary, NC). Duplicate records were identiﬁed
and deleted.
Variables extracted from records included sex (intact
female, spayed female, intact male, neutered male), age,
diagnosis code, visit year, and breed code. Age categories
included eight age ranges as recorded in the VMDB (2–6
months, 6–12 months, 1-2 years, 2–4 years, 4–7 years, 7–10
years, 10–15 years or >15 years). Due to the low incidence
of lymphoma in dogs less than 4 years of age, the 2–6
months, 6–12 months, 1-2 years, and 2–4 years categories
were combined into a less than 4-year category. The records
of control dogs less than 2 months of age were deleted from
the dataset because no lymphoma diagnoses were noted in
this age category. All records with unknown age, sex, breed,
visit year, or diagnosis codes were excluded.
Given the potential for confounding eﬀects of breed, and
age,apairedanalysiswasperformedforriskestimatesbysex.
In this analysis, a control record was selected for each case
record. Control records were matched ﬁrst on age and then
on breed. Due to the volume of records within the VMDB,
it was possible to match all controls and cases exactly for
both age and breed. When multiple matched controls were
available for a single case record, one control was randomly
selected. For each sex category a 2 × 2 table was generated,
based on the lymphoma status in each pair. In these tables,
cell A included paired data when both the case and control
members were of the sex under consideration, B when the
case was a member of the sex under consideration and the
control was not, C when the control was a member of the sex
category under consideration and the case was not, and D
when neither the case nor control member of the pair was
a member of the sex under consideration. Using matched
data, the odds ratio (OR) for lymphoma by speciﬁc sex
category was determined using as previously described for
matched data [14]. Thus, the risk of lymphoma for each sex
group was calculated compared to the matched case-control
population.
In addition, logistic regression models were developed
using all the cases and controls available in the VMDB to
predict the probability of the diagnosis of lymphoma as
a function of sex, breed, and age. Only breeds which had
a signiﬁcance (P<. 001) on a univariate analysis were
considered; all breeds without signiﬁcance were grouped as
“other pure breeds” for the multivariate analysis. Regression
coeﬃcients were used to calculate the odds ratio with 95%
conﬁdence intervals for each breed, estimating the risk of
the diagnosis of lymphoma relative to the mixed breedJournal of Cancer Epidemiology 3
Table 1: Sex distribution of lymphoma dogs evaluated in the
VMDB (1964–2002).
Sex Case (%) Control (%)
All Females 6,936 (47.6) 582,941 (50.4)
All Males 7,637 (52.4) 574,401 (49.6)
Female Intact 1,704 (11.7) 301,208 (26.0)
Female Spayed 5,232 (35.9) 281,733 (24.4)
Male Intact 4,437 (30.4) 435,313 (37.6)
Male Castrated 3,200 (22.0) 139,088 (12.0)
Table 2: Odds Ratio and 95% Conﬁdence Intervals for the paired
(breed and age) data for Canine Lymphoma in the VMDB (1964–
2002).
Sex Odds ratio 95% conﬁdence interval
Intact Female 0.69 0.63, 0.74
Spayed female 1.02 0.96, 1.08
Intact Male 1.32 1.24, 1.41
Neutered Male 0.91 0.85, 0.97
population. Only breeds with signiﬁcant diﬀerence in the
multivariate analysis are presented in the results table.
Comparative data for human NHL were gathered
from the SEER website. ( SEER Cancer Statistics Review,
1975–2003, National Cancer Institute. Bethesda, MD,
http://seer.cancer.gov/csr/1975 2003/,b a s e do nN o v e m b e r
2005 SEER data submission, posted to the SEER website,
2006. The U. S. Government, National Cancer Institute, and
their employees do not make any implicit or implied opinion
on the subject of this paper.) Utilizing the fast stats tool, a
query of age-adjusted rates for the incidence of NHL was
performed from 1975 to 2005 for all races. Age was limited
to <50 years for Figure 1 and >50 years for Figure 3 (data
downloaded on January 20, 2009).
3. Results
A total of 1,171,915 individual canine records were present
in the VMDB from 1964 to 2002; 1,157,342 constituted
the control population and 14,573 the case population.
A diagnosis of lymphoma is listed in 1.2% of the total
accessions in the VMDB. Sex distribution of lymphoma dogs
evaluated at North American veterinary teaching hospitals
from 1964 to 2002 is presented in Table 1. Age distribution
is presented in Table 3.
To evaluate the eﬀect of sex on lymphoma over those
38 years, 14,573 case-control pairs were identiﬁed based on
age and breed. Table 2 presents the odds ratios and 95%
conﬁdence interval for the development of lymphoma for
each speciﬁc sex category. All intervals are mutually exclusive
from each other. In the Logistic regression performed using
the unmatched data, the female intact category was also the
least likely to develop lymphoma.
The incidence of human NHL for all races in the
population <50 years of age according to sex was extracted
fromtheSEERdatabase(Figure 1).Itisapparentthatfemales
have a lower risk of developing NHL when compared to
males. This diﬀerence is consistent throughout the time span
under consideration. Figure 2 presents all intact dogs with
the diagnosis of lymphoma out of the total population by
year. The rate of a lymphoma diagnosis is lower in female
dogs for every year examined. For humans over 50 years
of age (Figure 3), the incidence diﬀerence between males
and females appears decreased. A similar decrease in the
diﬀerence between the rates appears for the altered canine
population (Figure 4).
Overall, a decreased risk of developing NHL is noted
in females of both the human and canine population. This
decrease is less apparent after 50 years of age in humans or
after sex alteration is performed in the canine population
(Figures 3 and 4).
Dogs of less than 4 years of age are less likely to develop
lymphoma compared to the rest of the population (Table 3).
The most commonly represented breeds in the lymphoma
group were mixed breed (n = 3,197), Golden retriever
(n = 1,474), Labrador retriever (n = 854), German
shepherd (n = 733), and Boxer (n = 677). When the
odds ratio for lymphoma was examined in those breeds with
more than one thousand control dogs, Bullmastiﬀ,B o x e r ,
Bernese mountain dog, Scottish terrier and Golden setters
had the highest risk of lymphoma (Table 4). These breed
predispositions may represent heritable factors contributing
to increased frequency in these breeds. Elucidation of such
genetic factors may help identify risk within human families
or ethnic groups at higher risk for developing NHL.
4. Discussion
To the authors’ knowledge, this is the only speciﬁc epidemio-
logicevaluationofsexriskforcaninelymphoma.TheVMDB
is one of the most comprehensive databases in veterinary
medicine, containing more than six million visit records.
The VMDB was queried only to 2002 because after that
year, the enrollment of cases was less consistent. With an
extensive number of cases from multiple veterinary teaching
hospitals across North America, geographical bias has likely
beenminimized.Ageandbreedbiasmustalsobeconsidered.
To address this bias, we paired each individual lymphoma
case with a randomly picked control of identical age category
and breed variable. One of the major weaknesses of the data
collected from the VMDB is possible misclassiﬁcation error
when data is entered; however, this should be random and
eliminated with the design used in this study.
We conclude that the epidemiologic data from the
VMDB supports a similar decreased risk for intact female
dogs, as for women who have a lower risk than men of
developing lymphoma. This sex eﬀect has been consistent
over the past few decades for both species. An interesting
diﬀe r e n c ei sn o t e df o rt h ea l t e r e dd o ga n da g e dh u m a n
population, where the diﬀerence in incidence of lymphoma
in males and females becomes signiﬁcantly smaller. We
theorize that this diﬀerence may be attributed to the
hormonal changes that occur once dogs are sexually altered
via ovariohysterectomy (spay), similar to when women reach4 Journal of Cancer Epidemiology
Table 3: Logistic regression model deﬁning the risk of a diagnosis of lymphoma in dogs in the VMDB (1964–2002) as a function of age.
Age Group Case (%) Control (%) Odds Ratio 95% C.I. P-value
Less than 4 years 1,791 (12.3) 606,667 (52.4) 1 ∗∗
4–7 years 4,626 (31.7) 222,206 (19.2) 6.73 (6.36, 7.11) <.0001
7–10 years 4,385 (30.1) 173,877 (15.0) 7.78 (7.35, 8.24) <.0001
10–15 years 3,553 (24.4) 142,778 (12.4) 8.06 (7.60, 8.55) <.0001
More than 15 years 218 (1.5) 11,814 (1.0) 6.96 (6.03, 8.03) <.0001
∗Baseline exposure; therefore coeﬃcient and P values are not provided and OR is deﬁned as 1.
Table 4: Logistic regression model deﬁning the risk of a diagnosis of lymphoma in dogs in the VMDB (1964–2002) as a function of breed.
Breed Case Control Odds Ratio 95% C.I. P value
Mix Breed 3140 270503 1 ∗∗
Bullmastiﬀ 51 1399 4.83 (3.62, 6.44) <.0001
Boxer 675 14541 4.05 (3.71, 4.41) <.0001
Bernese Mountain Dog 43 1301 3.64 (2.66, 4.96) <.0001
Scottish Terrier 261 5647 3.39 (2.98, 3.86) <.0001
Gordon Setter 50 1503 3.31 (2.48, 4.41) <.0001
Irish Wolfhound 60 2135 3.23 (2.48, 4.20) <.0001
Basset Hound 358 9945 3.22 (2.88, 3.60) <.0001
Golden Retriever 1462 41705 3.12 (2.93, 3.32) <.0001
Rottweiler 381 17174 2.71 (2.43, 3.02) <.0001
Vizsla 55 2041 2.66 (2.02, 3.49) <.0001
Bouvier des Flandres 42 1510 2.66 (1.94, 3.63) <.0001
Old English Sheepdog 158 5988 2.48 (2.11, 2.92) <.0001
Saint Bernard 176 9728 2.34 (2.01, 2.74) <.0001
Pembroke Welsh Corgi 47 1845 2.08 (1.55, 2.79) <.0001
Airedale Terrier 113 4778 1.92 (1.58, 2.32) <.0001
Samoyed 45 7199 0.55 (0.41, 0.74) <.0001
Brittany Spaniel 48 9116 0.48 (0.36, 0.64) <.0001
Maltese 27 5240 0.42 (0.29, 0.62) <.0001
Dutch Pug 24 5960 0.39 (0.26, 0.58) <.0001
Yorkshire Terrier 57 13549 0.35 (0.27, 0.45) <.0001
Poodle, Miniature 166 37939 0.29 (0.25, 0.34) <.0001
Pomeranian 27 8982 0.28 (0.19, 0.41) <.0001
Chihuahua 37 12522 0.28 (0.20, 0.38) <.0001
Poodle, Toy 46 17326 0.20 (0.15, 0.27) <.0001
Dachshund 68 26540 0.18 (0.15, 0.22) <.0001
Pekingese 21 10389 0.18 (0.12, 0.28) <.0001
∗Baseline exposure; therefore coeﬃcient and P values are not provided and OR is deﬁned as 1.
menopause. Due to the paucity of hormonally altered men,
we cannot compare the eﬀect of hormonal diﬀerences on
lymphoma risk in the male population. Dogs are commonly
neutered and hormonal changes are documented to occur.
Thus, the canine model provides a unique resource for the
studyofhormonalinﬂuenceonmaleNHLrisk.Womenwith
a history of oophorectomy had a very slight elevation in
risk compared to women with no such history [12]. Since
oophorectomy is not commonly performed, it is diﬃcult
to compare this practice to spaying in dogs. Therefore
for this study we have assumed that hormonal changes
that occur in women once they reach menopause are
similar to those that occur in female dogs when they are
altered. The elucidation of these hormonal changes after
menopause in humans or alteration in dogs bears further
investigation.
One of the limitations of this study is the lack of canine
lymphoma subtype classiﬁcation present in the VMDB. In
dogs, the clinical diagnosis of lymphoma is usually limited to
cell morphology, immunophenotype (CD3 for T cell, CD79a
for B cell), and assessment of nodal architectural [15]. Indo-
lent lymphomas, which are similar to low-grade lymphomas
of humans, are rarely recognized. The types of indolent
lymphoma reported in dogs include mantle cell, marginalJournal of Cancer Epidemiology 5
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Figure 1: Incidence for all races of human NHL in individuals
less than 50 years of age, adapted from the SEER webpage
(http://www.seer.cancer.gov/). Rates are adjusted to the 2000 US
Std. Population (19 age groups Census P25-1130).
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Figure 2: Rate of lymphoma in the intact canine population in the
VMDB.Dashedlinerepresentsfemaleintact(FI)dogsandsolidline
represents male intact (MI) dogs.
zone, follicular, and T-zone lymphomas [16]. Recent studies
suggest a genetic factor in the etiology of lymphoma due to
the breed association with immunophenotype and possibly
histological subtypes [17, 18]. In the human population,
NHL is known to be a complex and heterogeneous set of
lymphoma subtypes [19]. Subtypes include diﬀuse large
B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
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Figure 3: Incidence for all races of human NHL in individuals
greater than 50 years of age, adapted from the SEER webpage
(http://www.seer.cancer.gov/). Rates are adjusted to the 2000 US
Std. Population (19 age groups Census P25-1130).
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Figure 4: Rate of lymphoma in the canine altered population in the
VMDB. Dashed line represents female spayed (FS) dogs and solid
line represents male neutered (MN) dogs.
Estrogen and other reproductive hormones may aﬀect the
risk of NHL subtypes such as DLBCL [20]. In addition,
genetic variation and a wide variety of receptor haplotypes
havebeenidentiﬁedinhumanmedicine.Thisvariabilitymay
aﬀect the risk and outcome of canine lymphoma and human
NHL patients. More detailed prospective studies should be
performed to evaluate these diﬀerences.6 Journal of Cancer Epidemiology
When the multivariate logistic regression analysis was
performed, sex, age, and breed categories showed signiﬁ-
cance in the development of lymphoma. The category of 7–
10 years of age appears to be predisposed while less than 4
y e a r so fa g es e e m st ob el e s sl i k e l yt od e v e l o pl y m p h o m a .
Among breeds Bullmastiﬀ,B o x e r s ,B e r n e s eM o u n t a i nD o g
and Scottish terriers showed an increased risk of lym-
phoma. Dachshund and Pekingese were less frequent than
background. These ﬁndings are consistent with previously
published data and may represent genetic susceptibility or
protection [21].
Over the last decade, the relevance of veterinary com-
parative oncology to pharmaceutical and human medical
oncology research has been recognized. The movement
toward utilizing canine models in human medical research
is primarily due the previously mentioned strengths of the
canine model and the similarities between dogs and humans.
In addition, the Comparative Oncology Trials Consortium
(COTC) has formalized eﬀorts to use companion dogs in
human research by bringing together various institutions
to work under the umbrella institution of the National
Cancer Institute. The advantages of these eﬀorts include
rapid case accrual, decrease in the geographical distribution
bias, and minimization of operational bias. More recently
the creation of the Canine Comparative Oncology and
Genomics Consortium (CCOGC) has opened the door for
future studies of comparative animal models, accessible via a
centralized biospecimen repository.
In conclusion, human NHL and canine lymphomas
are similar diseases, making the dog an attractive model
for this comparative evaluation. Our data emphasizes the
similarcorrelationbetweenpresumptivehormonestatusand
development of lymphoma in both species. Results of this
analysis provide justiﬁcation for further investigation of the
hormonal inﬂuence on the risk of developing lymphoma.
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